Para-Time S. R. Drug Interactions
Currently displaying 128 drugs known to have a moderate interaction with Para-Time S. R. (papaverine).
Moderate interactions with Para-Time S. R. (papaverine)
Note: Showing generic names only.
A
- acetylcarbromal
- alfentanil
- alprazolam
- alprostadil
- amifostine
- amobarbital
- apraclonidine ophthalmic
- arginine
- asciminib
- avanafil
B
- baclofen
- bexagliflozin
- brexpiprazole
- brimonidine ophthalmic
- brimonidine topical
- bupropion
- buspirone
- butabarbital
- butalbital
- butorphanol
C
- cabergoline
- canagliflozin
- cannabis
- cariprazine
- carisoprodol
- chloral hydrate
- chlordiazepoxide
- chlormezanone
- chlorphenesin
- chlorzoxazone
- citrulline
- clobazam
- clonazepam
- clorazepate
- codeine
- cyclobenzaprine
D
E
F
G
H
I
L
M
- maraviroc
- meperidine
- mephobarbital
- meprobamate
- metaxalone
- methdilazine
- methocarbamol
- metronidazole
- midazolam
- minoxidil topical
- molindone
- morphine liposomal
N
O
P
- paraldehyde
- pentazocine
- pentobarbital
- pentoxifylline
- perphenazine
- phenelzine
- phenobarbital
- phentolamine
- polyethylene glycol 3350 with electrolytes
- procarbazine
- propiomazine
- pyrilamine
Q
R
S
- safinamide
- secobarbital
- selegiline
- selexipag
- sildenafil
- sodium oxybate
- sotagliflozin
- sparsentan
- sufentanil
T
V
Y
Z
Para-Time S. R. alcohol/food interactions
There is 1 alcohol/food interaction with Para-Time S. R. (papaverine).
Para-Time S. R. disease interactions
There are 2 disease interactions with Para-Time S. R. (papaverine) which include:
More about Para-Time S. R. (papaverine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Drug class: peripheral vasodilators
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.